Arcellx

ACLX48

$84.14arrow_drop_down0.54%-$0.46

ACLX48

$84.14

arrow_drop_down0.54%-$0.46

Performance History

Key Stats
Open	$84.68
Prev. Close	$84.43
EPS	-1.04
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	84.39	86.15
52 Week Range	30.88	88.66

Ratios







EPS	-1.04

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Arcellx (ACLX)

Arcellx, Inc. (ACLX) is a biotechnology company that focuses on the development of novel cell therapies for the treatment of cancer and other diseases. The company is headquartered in Gaithersburg, Maryland and was founded in 2015. Arcellx is committed to bringing innovative therapies to patients by harnessing the power of the immune system to selectively target and eliminate cancer cells. The company's platform technology, known as ARC-SparX, enables the engineering of highly potent and specific T cells to recognize and kill cancer cells. This approach has the potential to revolutionize cancer treatment by providing a more targeted and effective therapy.

Arcellx's stock price history reflects the growing interest and excitement surrounding the company's innovative cell therapy platform. Since going public, the stock has experienced significant growth, driven by positive clinical trial results and increasing investor confidence. The stock has seen strong momentum over the past year, reaching new highs and outperforming the broader market. Investors have been drawn to Arcellx's potential to disrupt the cancer treatment landscape and provide a more effective and personalized approach to therapy.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Headquarters: Gaithersburg
Employees: 98
Exchange: NASDAQ

Keep an eye on Arcellx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Arcellx's (ACLX) price per share?

The current price per share for Arcellx (ACLX) is $84.14. The stock has seen a price change of -$0.46 recently, indicating a -0.54% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Arcellx (ACLX)?

For Arcellx (ACLX), the 52-week high is $88.66, which is 5.37% from the current price. The 52-week low is $30.88, the current price is 172.47% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Arcellx (ACLX) a growth stock?

Arcellx (ACLX) has shown an average price growth of 0.41% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Arcellx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Arcellx (ACLX) stock price performance year to date (YTD)?

As of the latest data, Arcellx (ACLX) has a year-to-date price change of 49.85%. Over the past month, the stock has experienced a price change of 17.02%. Over the last three months, the change has been 56.42%. Over the past six months, the figure is 22.24%.

help

Is Arcellx (ACLX) a profitable company?

Arcellx (ACLX) has a net income of -$70.69M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -127.79% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $110.32M, although specific revenue growth data is currently not available. The gross profit is $108.28M. Operating income is noted at -$89.88M. Furthermore, the EBITDA is -$77.43M.

help

What is the market capitalization of Arcellx (ACLX)?

Arcellx (ACLX) has a market capitalization of $4.54B. The average daily trading volume is 558.26K, indicating the stock's liquidity and investor engagement.